Cargando...

Investigational Drug Treatments for Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer (BC) and accounts for 10–20% of cases. Due to the lack of expression of several receptors, hormone therapy is largely ineffective for treatment purposes. Nevertheless, TNBC often responds very well to chemotherapy, which...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Pers Med
Main Authors: Damaskos, Christos, Garmpis, Nikolaos, Garmpi, Anna, Nikolettos, Konstantinos, Sarantis, Panagiotis, Georgakopoulou, Vasiliki E., Nonni, Afroditi, Schizas, Dimitrios, Antoniou, Efstathios A., Karamouzis, Michalis V., Nikolettos, Nikos, Kontzoglou, Konstantinos, Patsouras, Alexandros, Voutyritsa, Errika, Syllaios, Athanasios, Koustas, Evangelos, Trakas, Nikolaos, Dimitroulis, Dimitrios
Formato: Artigo
Idioma:Inglês
Publicado: MDPI 2021
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8303312/
https://ncbi.nlm.nih.gov/pubmed/34357119
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jpm11070652
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!